Agnė Vaitkevičienė

On April 17-20, a delegation of Lithuanian companies participated in the life sciences forum “CEBioForum 2023”

On April 17-20, a delegation of Lithuanian companies participated in a business mission to Poland organized by LithuaniaBIO, during which Aušrinė Armonaitė, Minister of the Ministry of Economy and Innovation of the Republic of Lithuania, opened the life sciences forum “CEBioForum 2023“. During the event, LithuaniaBIO president Tomas Andrejauskas, together with the minister, participated in…

Atrandi Biosciences Secures Funding and Advances Global Commercialization of Next-Gen Single Cell Analysis Technology

● €4.5 million funding from Vsquared Ventures, Practica Capital and Metaplanet, bringing total funding to €8 million; ● New capital will support a worldwide commercial organisation, enabling a direct U.S. presence; ● Launch of new semi-permeable capsule technology to unlock breakthroughs in scientific discovery and innovation. VILNIUS, Lithuania and DENVER, CO, March 23, 2023 –…

Members of LithuaniaBIO and Lithuanian life sciences and biotechnology business representatives were on a business mission to Italy, Milan, on March 7 – 9

LithuaniaBIO together with the Invest Lithuania, the Ministry of Economy and Innovation and Lithuanian life sciences and biotechnology business representatives were on a business mission in Italy on March 7-9. During the business mission representatives from Lithuania visited the OpenZone cluster. A campus funded entirely by private capital, dedicated to Health and founded on an…

Members of the Lithuanian biotechnology association participated at the exhibition Arab Health 2023, Dubai, United Arab Emirates

Members of the Lithuanian biotechnology association participated in the exhibition Arab Health 2023, held in Dubai, United Arab Emirates on January 29 – February 2. The Arab Health 2023 is international exhibition of health care and medical technologies held in Dubai. Exhibition attracted as many as 2,828 exhibitors from 70 countries worldwide. The event attracted…

Record growth of the Lithuanian biotechnology sector: last year the company’s income approached three billion

The Lithuanian biotechnology sector continues to grow consistently – according to the Lithuanian Biotechnology Association (LBTA), last year the revenues of companies in this sector amounted to 2.6 billion. EUR (EUR 1.9 billion in 2020), and one private sector worker generated approximately EUR 0.95 million. EUR of income (EUR 0.78 million in 2020). The number…

October 25 the scientific symposium “Gene editing – from research to industry” organized by the Lithuanian Biotechnology Association took place

The scientific symposium “Gene editing – from research to industry” organized by the Lithuanian Biotechnology Association together with partners took place! During the event, we heard many interesting and useful presentations and success stories of research outcomes in the field of gene editing. The symposium was attended by genetic engineering specialists from academia and industry.…